| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
11,202 |
8,920 |
$1.33M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,601 |
20,354 |
$1.22M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,817 |
7,767 |
$720K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,772 |
3,624 |
$267K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,365 |
6,988 |
$107K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,569 |
2,365 |
$104K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,045 |
2,923 |
$84K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,070 |
1,038 |
$62K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,478 |
1,045 |
$30K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
462 |
375 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
263 |
201 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
155 |
94 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
21 |
12 |
$276.95 |
| 81003 |
|
80 |
75 |
$138.61 |
| 81002 |
|
30 |
15 |
$40.95 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
47 |
24 |
$12.80 |
| A9150 |
Non-prescription drugs |
43 |
25 |
$0.00 |